As of Apr 30, 2024, the HAE stock has a PE ratio of 36.78. The calculation is based on the latest EPS of $2.5 and the stock price of $91.95 per share. An increase of 7% has been observed in the PE ratio compared to its average of 34.4 of the last four quarters.
The mean historical PE ratio of Haemonetics over the last ten years is 112.67. The current 36.78 P/E ratio is 67% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Jul 2023 quarter marked the lowest point at 31.65, with a price of $85.14 and an EPS of $2.69.
Maximum annual increase: 183.71% in 2015
Maximum annual decrease: -51.48% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 36.45 | -51.48% |
| 2022 | 75.12 | 5.27% |
| 2021 | 71.36 | 6.75% |
| 2020 | 66.85 | -18.24% |
| 2019 | 81.76 | -3.89% |
| 2018 | 85.07 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | 133.97 | 183.71% |
| 2014 | 47.22 | -13.86% |
The current PE ratio of HAE is lower than its 3, 5 and 10-year averages.
In comparison to its peers SYK and BDX, HAE's PE ratio is lower, but it is higher than JNJ's and TMO's. Haemonetics's PE ratio is trading above the peer average of 29.34.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BAX Baxter International Inc | 7.68 | $20.49B |
| JNJ Johnson & Johnson | 10.89 | $364.16B |
| MDT Medtronic plc | 25.68 | $107.41B |
| HAE Haemonetics Corp | 36.85 | $4.68B |
| TMO Thermo Fisher Scientific Inc | 37.05 | $219.25B |
| SYK Stryker Corp | 39.34 | $124.77B |
| BDX Becton Dickinson & Co | 55.25 | $67.52B |
| CERS Cerus Corp | N/A | $311.81M |
As of Apr 30, 2024, HAE stock has a price to earnings ratio of 36.78.
The 3-year average price to earnings ratio for HAE stock is 58.51.
The 5-year average price to earnings ratio for HAE stock is 64.05.
Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.
HAE's current price to earnings ratio is 67% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 30, 2024), Haemonetics's share price is $91.95. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $2.5. Therefore, Haemonetics's PE ratio for today is 36.78. PE RATIO(36.78) = STOCK PRICE($91.95) / TTM EPS($2.5)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.